MCL coexpression mm9:966
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr15:78744346..78744357,+ | p2@Pdxp |
Mm9::chr19:16207236..16207263,+ | p3@Gnaq |
Mm9::chr19:5093003..5093016,- | p@chr19:5093003..5093016 - |
Mm9::chr1:91476758..91476777,+ | p@chr1:91476758..91476777 + |
Mm9::chr2:153355941..153355988,- | p3@8430427H17Rik |
Mm9::chr3:89263219..89263243,+ | p4@Pmvk |
Mm9::chr5:24414378..24414401,- | p9@Prkag2 |
Mm9::chr7:54388068..54388082,- | p9@Ptpn5 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0006695 | cholesterol biosynthetic process | 0.00195623805134542 |
GO:0016126 | sterol biosynthetic process | 0.00195623805134542 |
GO:0008203 | cholesterol metabolic process | 0.00476738807664171 |
GO:0006694 | steroid biosynthetic process | 0.00476738807664171 |
GO:0016125 | sterol metabolic process | 0.00476738807664171 |
GO:0004631 | phosphomevalonate kinase activity | 0.00735038989024635 |
GO:0050932 | regulation of pigment cell differentiation | 0.0102920334871923 |
GO:0045634 | regulation of melanocyte differentiation | 0.0102920334871923 |
GO:0008202 | steroid metabolic process | 0.0102920334871923 |
GO:0016322 | neuron remodeling | 0.0160319429526234 |
GO:0060158 | dopamine receptor, phospholipase C activating pathway | 0.0160319429526234 |
GO:0021884 | forebrain neuron development | 0.0176312726477465 |
GO:0016791 | phosphoric monoester hydrolase activity | 0.0176312726477465 |
GO:0008610 | lipid biosynthetic process | 0.0176312726477465 |
GO:0004679 | AMP-activated protein kinase activity | 0.0176312726477465 |
GO:0006066 | alcohol metabolic process | 0.018147850684892 |
GO:0021879 | forebrain neuron differentiation | 0.018147850684892 |
GO:0021872 | generation of neurons in the forebrain | 0.0195860098829364 |
GO:0042578 | phosphoric ester hydrolase activity | 0.0198286620026463 |
GO:0042551 | neuron maturation | 0.0198286620026463 |
GO:0007215 | glutamate signaling pathway | 0.0209804118909944 |
GO:0042733 | embryonic digit morphogenesis | 0.0260262263429269 |
GO:0006471 | protein amino acid ADP-ribosylation | 0.0299370552228139 |
GO:0030318 | melanocyte differentiation | 0.0299370552228139 |
GO:0050931 | pigment cell differentiation | 0.0299370552228139 |
GO:0007212 | dopamine receptor signaling pathway | 0.0304755625900123 |
GO:0021954 | central nervous system neuron development | 0.0342267238762276 |
GO:0021953 | central nervous system neuron differentiation | 0.0377068485994009 |
GO:0044255 | cellular lipid metabolic process | 0.0402783680354601 |
GO:0016776 | phosphotransferase activity, phosphate group as acceptor | 0.0410405751465139 |
GO:0048066 | pigmentation during development | 0.0411306312227698 |
GO:0007200 | G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) | 0.0412147581446118 |
GO:0009791 | post-embryonic development | 0.0412934949740724 |
GO:0005834 | heterotrimeric G-protein complex | 0.042655371467583 |
GO:0006629 | lipid metabolic process | 0.042717818550928 |
GO:0007189 | G-protein signaling, adenylate cyclase activating pathway | 0.042717818550928 |
GO:0001508 | regulation of action potential | 0.0429220077924235 |
GO:0016788 | hydrolase activity, acting on ester bonds | 0.0429220077924235 |
GO:0016787 | hydrolase activity | 0.0478159390112852 |
GO:0048015 | phosphoinositide-mediated signaling | 0.0482845165637295 |
Relative expression of the co-expression cluster over median <br>Analyst:
"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |